Outlook Therapeutics, Inc. (OTLK) Tops Q1 EPS by 1c
Get Alerts OTLK Hot Sheet
Join SI Premium – FREE
Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Outlook Therapeutics, Inc. (OTLK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
- Argus Starts SpaceX (SPCX) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share